# FDA Inspection 1293588 - Henry Schein Inc - September 22, 2025

Source: https://www.keypedia.com/records/fda_inspections/henry-schein-inc/28dc8a24-fd5c-4f1b-b643-f9b4cf2df15f
Source feed: FDA_Inspections

> FDA Inspection 1293588 for Henry Schein Inc on September 22, 2025. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1293588
- Company Name: Henry Schein Inc
- Inspection Date: 2025-09-22
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1311236 - 2026-04-02](https://www.keypedia.com/records/fda_inspections/henry-schein-inc/02e6693a-bbc7-4f50-80f5-80d8fc5b1716)
- [FDA Inspection 1210652 - 2023-07-13](https://www.keypedia.com/records/fda_inspections/henry-schein-inc/b4b6c64c-0504-4d24-a337-84358eeba37b)
- [FDA Inspection 1016997 - 2017-06-29](https://www.keypedia.com/records/fda_inspections/henry-schein-inc/9eed042c-9fc3-4813-aef1-9fe5f3d17684)

Company: https://www.keypedia.com/companies/henry-schein-inc/f768bc47-6d11-4e14-8556-42382f4bbc33

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d